Literature DB >> 19323

The fate of bilirubin-IXalpha glucuronides in cholestatic bile: sequential migration of the 1-acylaglycone to the 2-, 3- and 4- positions of glucuronic acid.

F Compernolle, N Blanckaert, K P Heirwegh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 19323     DOI： 10.1042/bst0050317

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN： 0300-5127            Impact factor:   5.407


× No keyword cloud information.
  5 in total

1.  Conjugated and unconjugated bilirubins in humans and rhesus monkeys. Structural identity of bilirubins from biles and meconiums of newborn humans and rhesus monkeys.

Authors:  S G Blumenthal; D B Taggart; R D Rasmussen; R M Ikeda; B H Ruebner; D E Bergstrom; F W Hanson
Journal:  Biochem J       Date:  1979-06-01       Impact factor: 3.857

2.  Structure revision of disaccharidic conjugates of bilirubin-IX alpha in human bile and identification of phenylazo derivatives B4, B5, and B6 as 2-, 3- and 4-O-acylglucuronides.

Authors:  F Compernolle
Journal:  Biochem J       Date:  1978-12-01       Impact factor: 3.857

3.  Glucuronic acid conjugates of bilirubin-IXalpha in normal bile compared with post-obstructive bile. Transformation of the 1-O-acylglucuronide into 2-, 3-, and 4-O-acylglucuronides.

Authors:  F Compernolle; G P Van Hees; N Blanckaert; K P Heirwegh
Journal:  Biochem J       Date:  1978-04-01       Impact factor: 3.857

4.  The fate of bilirubin-IXalpha glucuronide in cholestasis and during storage in vitro. Intramolecular rearrangement to positional isomers of glucuronic acid.

Authors:  N Blanckaert; F Compernolle; P Leroy; R Van Houtte; J Fevery; K P Heirwegh
Journal:  Biochem J       Date:  1978-04-01       Impact factor: 3.857

5.  Comparison in different species of biliary bilirubin-IX alpha conjugates with the activities of hepatic and renal bilirubin-IX alpha-uridine diphosphate glycosyltransferases.

Authors:  J Fevery; M Van de Vijver; R Michiels; K P Heirwegh
Journal:  Biochem J       Date:  1977-06-15       Impact factor: 3.857
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.